Spire Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.6K | Sell |
|
|||||
|
2025
Q1 | $114K | Buy |
|
|||||
|
2024
Q4 | $113K | Buy |
|
|||||
|
2024
Q3 | $152K | Buy |
|
|||||
|
2024
Q2 | $122K | Sell |
|
|||||
|
2024
Q1 | $171K | Sell |
|
|||||
|
2023
Q4 | $174K | Sell |
|
|||||
|
2023
Q3 | $157K | Sell |
|
|||||
|
2023
Q2 | $6.43M | Buy |
|
|||||
|
2023
Q1 | $7.22M | Buy |
|
|||||
|
2022
Q4 | $108K | Buy |
|
|||||
|
2022
Q3 | $63K | Sell |
|
|||||
|
2022
Q2 | $349K | Sell |
|
|||||
|
2022
Q1 | $483K | Sell |
|
|||||
|
2021
Q4 | $527K | Buy |
|
|||||
|
2021
Q3 | $410K | Buy |
|
|||||
|
2021
Q2 | $128K | Sell |
|
|||||
|
2021
Q1 | $211K | Buy |
|